Invesco Biotechnology & Genome ETF (PBE) Holdings List $82.15 0.00 (0.00%) As of 05/22/2026 04:10 PM Eastern Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock What stocks does PBE hold? The Invesco Biotechnology & Genome ETF (PBE) top stock holdings include United Therapeutics, Illumina, and Biogen. The top 25 PBE holdings ordered by weight make up 89.82% of the total fund. PBE is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete PBE stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure. Top 25 PBE HoldingsRankCompanyCurrent PriceWeightShares Held1UTHRUnited Therapeutics$568.436.03%27,0382ILMNIllumina$144.415.85%104,1583BIIBBiogen$193.764.87%65,6014INCYIncyte$97.164.87%126,6795ALNYAlnylam Pharmaceuticals$297.454.54%38,4586GILDGilead Sciences$134.364.48%86,7027AMGNAmgen$339.304.39%33,4358REGNRegeneron Pharmaceuticals$638.884.26%16,5769TGTXTG Therapeutics$38.873.60%228,85310CPRXCatalyst Pharmaceuticals$31.263.57%288,645 Get the Latest News and Ratings for PBE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Invesco Biotechnology & Genome ETF and its competitors with MarketBeat's FREE daily newsletter. 11VCYTVeracyte$45.033.50%195,63712ARWRArrowhead Pharmaceuticals$74.953.35%109,66413NBIXNeurocrine Biosciences$156.703.26%53,31414RPRXRoyalty Pharma$54.503.23%153,79515PTGXProtagonist Therapeutics$99.193.19%79,89716BCRXBioCryst Pharmaceuticals$8.293.17%917,52017EXELExelixis$50.153.05%154,68018CDNACareDx$21.633.03%362,71719PTCTPTC Therapeutics$68.812.84%101,22120HALOHalozyme Therapeutics$68.322.71%99,23821VCELVericel$34.732.56%182,54422IONSIonis Pharmaceuticals$75.562.43%81,71223TBPHTheravance Biopharma$16.372.40%366,33224ACADACADIA Pharmaceuticals$21.102.35%283,94925RGENRepligen$115.062.29%51,847 PBE Geographic ExposurePBE's largest geographic exposure is United States at 95.7%, followed by Cayman Islands at 2.4%.United States95.7%Cayman Islands2.4%Netherlands2.0%PBE Currency ExposurePBE is exclusively exposed to USD.USD98.1%PBE Sector ExposurePBE's largest sector exposure is Health Care at 98.1%.Health Care98.1%PBE Industry ExposurePBE's largest industry exposure is Biotechnology at 80.7%, followed by Health Care Equipment & Supplies at 17.3%.Biotechnology80.7%Health Care Equipment & Supplies17.3%PBE Sub-Industry ExposurePBE's largest sub-industry exposure is Biotechnology at 80.7%, followed by Life Sciences Tools & Services at 14.2%.Biotechnology80.7%Life Sciences Tools & Services14.2%Health Care Equipment3.1% Related Companies and Tools Related Companies Simplify Health Care ETF Portfolio Invesco Pharmaceuticals ETF Portfolio ALPS Medical Breakthroughs ETF Portfolio SPDR S&P Pharmaceuticals ETF Portfolio VanEck Biotech ETF Portfolio Direxion Daily Healthcare Bull 3x Shares Portfolio Invesco S&P SmallCap Health Care ETF Portfolio SPDR S&P Health Care Equipment ETF Portfolio Invesco Dorsey Wright Healthcare Momentum ETF Portfolio SPDR S&P Health Care Services ETF Portfolio This page (NYSEARCA:PBE) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
